Sort
15,842 grants matching “pancreatic cancer”
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors
$544,735William C Zamboni · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors
$544,735William C Zamboni · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
$544,659Chi V. Dang · Johns Hopkins University · R01 · FY2023 · CA
Using markers to improve pancreatic cancer screening and surveillance: a multi-center study
$544,589Michael G. Goggins · Johns Hopkins University · U01 · FY2023 · CA
Real-time monitoring of circulating pancreatic tumor cells and clusters
$544,582Erica Carpenter · University Of Pennsylvania · R01 · FY2016 · CA
Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS
$544,547John R Engen · Northeastern University · R01 · FY2020 · CA
Project 2
$544,481Paolo Provenzano · University Of Minnesota · P01 · FY2023 · CA
Project 2
$544,481Paolo Provenzano · University Of Minnesota · P01 · FY2022 · CA
Project 2: Identifying Metabolic vulnerabilities and targets in cancers with mutations in hamartoma genes
$544,210David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2021 · CA
Project 2: Identifying Metabolic vulnerabilities and targets in cancers with mutations in hamartoma genes
$544,210David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2020 · CA
Targeting MTOR signaling in pancreatic cancer
$544,134Brian C Lewis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
$544,035Albert Koong · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
POSITIONAL CLONING OF THE MEN1 GENE
$544,018Settara Chandrasekharappa · National Human Genome Research Institute · ZIA · FY2009 · HG
Nanovaccine platforms to combat pancreatic cancer
$543,977Balaji Narasimhan · Iowa State University · U01 · FY2018 · CA
Metarrestin for the Treatment of Pancreatic Cancer
$543,703Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Protein Structure, Stability, and Amyloid Formation
$543,630Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Interrogation of the Impact of Selection on the Evolution of Human Pancreatic Cancer Precursor Lesions
$543,627Laura Delong Wood · Johns Hopkins University · U01 · FY2022 · CA
Ultrasound-enhanced drug penetration for treatment of pancreatic cancer
$543,588Joo H Hwang · Stanford University · R01 · FY2021 · CA
Biomedical Computing Tools for Pancreatic Cancer Res.
$543,090University Of Nebraska Medical Center · R33 · FY2005 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$542,980David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Mechanism and therapeutic targeting of evasive resistance to antiangiogenic drugs
$542,459Gabriele Bergers · University Of California, San Francisco · R01 · FY2010 · CA
Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan)
$542,270Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Immune Enhancement and Therapy of Cancer
$542,182University Of California San Francisco · U01 · FY2004 · CA
Modeling response to MAPK Inhibitors
$542,126Wolfgang Michael Korn · Oregon Health & Science University · U54 · FY2012 · CA
Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
$541,606Peter J Allen · Duke University · R01 · FY2023 · CA